Relpax Patent Fight Revived After Stalled Settlement
A New York federal judge on Tuesday reopened Pfizer Inc.'s patent infringement suit against Apotex Inc. over the company's plan to sell a generic version of the migraine drug Relpax, after...To view the full article, register now.
Already a subscriber? Click here to view full article